Serum Inflammatory Protein Concentration During Dental Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-75
SponsorOhio State University

About this trial

The goal of this observational study is to study the molecular markers of stress in blood samples from people who are having periodontal surgery. The main question it aims to answer are:

* How do the levels of inflammatory molecules in the blood change during a periodontal surgery? * How are the levels of inflammatory molecules in a person having surgery different from the levels in a person having a nonsurgical procedure? * Participants will be people who are having a periodontal surgery or a nonsurgical periodontal treatment as part of their dental care. Participants will be asked to let the investigator take blood samples from them before, during, and after the procedure is being done. The blood will later be analyzed for substances in the blood that are associated with inflammation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults 21-75 years of age

Systemically healthy

Non-smoker

scheduled to receive nonsurgical or surgical periodontal treatment under IV sedation

Disqualifiers

Patients who have localized form of the disease (less than 30% of available tooth/implant sites are affected with the disease)

Non-english speaking individuals since informed consent form will be in English only.

Patients with uncontrolled systemic diseases (such as metabolic diseases, obesity, diabetes, high blood pressure) since these types of chronic inflammatory challenges would cause increase levels of circulatory serum pro-inflammatory markers.

Pregnant patients (pregnancy will be reported by the patient) since pregnancy itself would affect circulatory serum pro-inflammatory markers.

Trial population

Study population will be created from the general patient population that is referred to The Ohio State University College of Dentistry's Advanced Training in Periodontology clinics or already established patients in our clinics. These are adult patients suffering from gum disease, losing teeth due to disease and/or having disease around their dental implants. There will be two groups: Control group 1 will be recruited from the patients who have already received active treatment to control their disease and are now in periodontal maintenance program (regular cleaning). Control group 2 will be recruited from patients who are receiving non-surgical deep cleaning (debridement under local anesthesia) and Test group will be recruited from patients who are treatment planned for periodontal/peri-implant surgical interventions.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Blood samples for inflammatory markers

    Other intervention

    Blood samples will be obtained before the start of the procedure, the midpoint of the procedure, and the end of the procedure.

  • periodontal surgery

    Procedure/Surgery

    Periodontal/peri-implant surgical interventions, with or without IV sedation, as based on treatment needs

  • Periodontal maintenance

    Procedure/Surgery

    Regular cleaning to maintain health after surgical treatment for periodontal disease

  • Non-surgical deep cleaning

    Procedure/Surgery

    Debridement under local anesthesia, as based on treatment needs

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Control group 12 interventions
Group B: Control group 22 interventions
Group C: Surgical group2 interventions

Trial outcomes

Primary outcomes

1

Serum CRP concentration (pg/ml)

The investigators will study CRP concentration (pg/ml) in circulatory inflammatory mediator content during dental treatment by drawing peripheral blood samples, isolating serum and running a protein assay to detect inflammatory protein content in concentration (pg/ml) level.

Time frame
Immediately prior to procedure; approximately midway through the procedure; immediately after procedure ends;
2

Seum IL-1 concentration (pg/ml)

The investigators will measure serum IL-1 concentration (pg/ml) in blood samples obtained immediately before, during and immediately after the dental procedure.

Time frame
During dental procedure intervention
3

Serum TNF concentration (pg/ml)

The investigators will measure serum TNF concentration (pg/ml) during dental procedure.

Time frame
Blood samples will be obtained immediately before, during and immediately after dental procedure intervention.

Secondary outcomes

Other outcomes

1

Sedation Effect

The investigators will record whether the surgical procedure was performed under sedation, and will study the possible differential effect of sedation on low level circulatory inflammation.

Time frame
Immediately prior to procedure; approximately midway through the procedure; immediately after procedure ends;
2

Tissue change (mm)

Tissue change (mm), obtained as part of standard of care, will be collected from the participant's electronic health care record.

Time frame
Approximately 30 days after the procedure

Sponsors and contacts

Click on the lead sponsor to view all of their trials.